Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
Become a Member | Sign in
Home>News>This Article

Hamilton Puts the Accuracy and Precision of its Automated Liquid Handling Systems in the Hands of Laboratory Technicians

Published: Tuesday, January 22, 2013
Last Updated: Tuesday, January 22, 2013
Bookmark and Share
Hamilton Company’s Laboratory and Sensor Products Division introduces the Microlab 300 Series Pipettor, the industry’s first guided pipetting system.

The product is designed to bring the assurance of an automated liquid handling system into the hands of the laboratory technician at a low cost and without complex programming. This lightweight, hand-held device enables laboratories to achieve unsurpassed quality assurance through reproducible and traceable methods, and to reduce sample preparation time by eliminating inefficient steps.

“The innovative design of the Microlab 300 Series Pipettor replaces three to four manual or electronic pipettes with one device. Users can dispense between 0.5–1000 µL without needing to exchange pipettes,” says Jason March, Marketing Director of the Laboratory and Sensor Products Division. “The Microlab 300 achieves this range with just one probe and two tip sizes, instead of the three pipette sizes and three tip sizes typically required.”

The Microlab 300 meets GLP/GMP, RoHS, 21 CFR Part 11, and ISO-8655 regulations. The system also exceeds accuracy benchmarks set by the industry by allowing users to fine-tune pipetting parameters for each liquid.

“One of the core benefits of the Microlab 300 is its ability to improve pipetting accuracy through standard and customizable Liquid Classes,” says Devon Bateman, Product Manager for Hamilton Company. “Technicians can establish pipetting speeds and delays easily for any fluid, giving them the power to successfully pipette the most challenging liquids.”

The Microlab 300 is also unique because of its user-friendly, proprietary software. The system goes beyond pre-programmed pipetting operations for common techniques, like reverse pipetting and aliquoting, and allows technicians to easily create, save, and execute pipetting applications from start to finish. Users also benefit from a range of software advancements:

•    Linked Methods serve as electronic standard operating procedures and eliminate process errors by guiding the technician graphically through the pipetting steps in a controlled and auditable manner.
•    Sample volumes are automatically set by the system, eliminating manual adjustment errors.
•    Log files of all pipetting activities are generated and stored for traceability.
•    User accounts and password protection provide additional system security and accountability.

The Microlab 300 is currently available in North and South America, Australia and the Pacific Rim.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Lucentis Effective for Proliferative Diabetic Retinopathy
NIH-funded clinical trial marks first major advance in therapy in 40 years.
Blocking the Transmission Of Malaria Parasites
Vaccine candidate administered for the first time in humans in a phase I clinical trial led by Oxford University’s Jenner Institute, with partners Imaxio and GSK.
First Therapy Appearing to Reverse Decline in Parkinson’s
An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson’s disease and Lewy body dementia in a small clinical trial, say researchers at Georgetown University Medical Center (GUMC).
Gene Therapy Staves Off Blindness from Retinitis Pigmentosa in Canine Model
NIH-funded study suggests therapeutic window may extend to later-stage disease.
Treatment for Rare Bleeding Disorder is Effective
Researchers in Manchester have demonstrated for the first time the relative safety and effectiveness of treatment, eltrombopag, in children with persistent or chronic immune thrombocytopenia (ITP), as part of an international duo of studies.
HIV Vaccine Human Trials Begin
Baltimore-based Institute has begun enrolling volunteers for initial phase 1 clinical trials.
New Therapy Reduces Symptoms of Inherited Enzyme Deficiency
A phase three clinical trial of a new enzyme replacement medication, sebelipase alfa, showed a reduction in multiple disease-related symptoms in children and adults with lysosomal acid lipase deficiency, an inherited enzyme deficiency that can result in scarring of the liver and high cholesterol.
Fixing Holes in the Heart Without Invasive Surgery
UV-light enabled catheter is a medical device which represents a major shift in how cardiac defects are repaired.
Atriva Therapeutics GmbH Develops Innovative Flu Drug
Highly effective against seasonal and pandemic influenza.
Study Removes Cancer Doubt for Multiple Sclerosis Drug
Researchers from Queen Mary University of London are calling on the medical community to reconsider developing a known drug to treat people with relapsing Multiple sclerosis after new evidence shows it does not increase the risk of cancer as previously thought.
Scroll Up
Scroll Down

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos